Arbutamine: Difference between revisions
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
No edit summary |
||
| Line 24: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Arbutamine''' is a [[cardiac stimulant]]. It stimulates [[adrenergic receptor]]s.<ref name="pmid8723169">{{cite journal |author=Abou-Mohamed G, Nagarajan R, Ibrahim TM, Caldwell RW |title=Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing |journal=Cardiovasc Drugs Ther |volume=10 |issue=1 |pages=39–47 |date=March 1996 |pmid=8723169 |doi= 10.1007/BF00051129|url=}}</ref> | |||
== | ==References== | ||
{{reflist|2}} | |||
{{Adrenergic agonists}} | |||
{{Cardiac stimulants excluding cardiac glycosides}} | {{Cardiac stimulants excluding cardiac glycosides}} | ||
[[Category:Catecholamines]] | [[Category:Catecholamines]] | ||
[[Category:Drugs]] | [[Category:Cardiac stimulants]] | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drug]] | |||
Revision as of 00:41, 24 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C18H23NO4 |
| Molar mass | 317.38 g/mol |
|
WikiDoc Resources for Arbutamine |
|
Articles |
|---|
|
Most recent articles on Arbutamine |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Arbutamine at Clinical Trials.gov Clinical Trials on Arbutamine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Arbutamine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Arbutamine Discussion groups on Arbutamine Patient Handouts on Arbutamine Directions to Hospitals Treating Arbutamine Risk calculators and risk factors for Arbutamine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Arbutamine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Arbutamine is a cardiac stimulant. It stimulates adrenergic receptors.[1]
References
- ↑ Abou-Mohamed G, Nagarajan R, Ibrahim TM, Caldwell RW (March 1996). "Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing". Cardiovasc Drugs Ther. 10 (1): 39–47. doi:10.1007/BF00051129. PMID 8723169.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Catecholamines
- Cardiac stimulants
- Cardiovascular Drugs
- Drug